NASDAQ:SPRO

Spero Therapeutics Stock Predictions

etoro logo Buy SPRO
*Your capital is at risk
$2.80
-0.0300 (-1.06%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

SPRO Prediction Chart

SPRO Predictions History

Latest community submissions for SPRO.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 2, 2025 $2.41 -3.42% $2.74 X 88.12% 0
Jun 2, 2025 $2.45 -2.14% $2.74 X 89.29% 0
Jun 2, 2025 $3.00 +20.00% $2.74 V 90.51% 1
Dec 27, 2024 $0.96 +2.09% $1.03 V 93.56% 1
Dec 27, 2024 $0.96 +1.31% $1.03 V 92.84% 1
Dec 27, 2024 Bullish $1.03 V 1
Apr 15, 2024 $1.67 +2.05% $1.53 X 90.62% 0
Apr 15, 2024 $1.66 +1.28% $1.53 X 91.44% 0
Michael Emley Michael Emley @MichaelEmley.159077
Apr 15, 2024 Bullish $1.53 X 0
May 30, 2023 $1.81 +2.01% $1.77 X 97.99% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SPRO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SPERO THERAPEUTICS INC.
Spero Therapeutics
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct actin...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE